Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 18.4
(-0.38%)
CNY 18.4
(-0.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -174.21 Million CNY | 8.43% |
| 2022 | -190.24 Million CNY | 37.16% |
| 2021 | -302.72 Million CNY | -315.52% |
| 2020 | -72.85 Million CNY | -137.93% |
| 2019 | -30.62 Million CNY | 12.81% |
| 2018 | -35.12 Million CNY | 7.48% |
| 2017 | -37.95 Million CNY | -192.02% |
| 2016 | 41.25 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -75.53 Million CNY | 59.72% |
| 2024 Q3 | -33.84 Million CNY | 55.19% |
| 2024 Q1 | -187.53 Million CNY | -7.65% |
| 2023 Q3 | -230.8 Million CNY | -12.7% |
| 2023 Q2 | -204.8 Million CNY | 21.18% |
| 2023 Q1 | -259.82 Million CNY | -36.58% |
| 2023 FY | -174.21 Million CNY | 8.43% |
| 2023 Q4 | -174.21 Million CNY | 24.52% |
| 2022 Q4 | -190.24 Million CNY | 19.96% |
| 2022 Q3 | -237.67 Million CNY | 8.99% |
| 2022 Q2 | -261.14 Million CNY | 15.84% |
| 2022 Q1 | -310.28 Million CNY | -2.5% |
| 2022 FY | -190.24 Million CNY | 37.16% |
| 2021 Q2 | -494.58 Million CNY | -572.38% |
| 2021 FY | -302.72 Million CNY | -315.52% |
| 2021 Q1 | -73.55 Million CNY | -0.96% |
| 2021 Q4 | -302.72 Million CNY | -42.63% |
| 2021 Q3 | -212.24 Million CNY | 57.09% |
| 2020 Q4 | -72.85 Million CNY | 0.0% |
| 2020 FY | -72.85 Million CNY | -137.93% |
| 2020 Q1 | 84.52 Million CNY | 376.03% |
| 2020 Q2 | -60.97 Million CNY | -172.14% |
| 2019 Q2 | -37.28 Million CNY | 0.0% |
| 2019 Q4 | -30.62 Million CNY | -0.0% |
| 2019 Q3 | -30.62 Million CNY | 17.88% |
| 2019 FY | -30.62 Million CNY | 12.81% |
| 2019 Q1 | -37.28 Million CNY | 0.0% |
| 2018 FY | -35.12 Million CNY | 7.48% |
| 2017 FY | -37.95 Million CNY | -192.02% |
| 2016 FY | 41.25 Million CNY | 0.0% |